共有 50 笔近期内部人交易记录记录，涉及 Adverum Biotechnologies, Inc. (ADVM), 包括 39 笔买入 和 11 笔卖出. 内部人买入总额为 $9.09M 内部人卖出总额为 $13.71M.
近期活跃的重要内部人包括 Whitcup Scott M, Machado Patrick, Rubinstein Linda M. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ADVM
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2025-06-17 |
Whitcup Scott M |
Director |
限制性股票授予 (RSU) |
10,450 |
$2.32 |
$24.24K |
10,450 |
| 2025-06-17 |
Machado Patrick |
Director |
限制性股票授予 (RSU) |
3,140 |
$2.32 |
$7.28K |
3,140 |
| 2025-06-17 |
Rubinstein Linda M |
Chief Financial Officer |
股份退回 |
35,000 |
$19.90 |
$696.5K |
- |
| 2025-06-17 |
Scopa James Paul |
Director |
限制性股票授予 (RSU) |
10,450 |
$2.32 |
$24.24K |
10,450 |
| 2025-06-17 |
Fischer Laurent |
CEO, President and Director |
股份退回 |
68,000 |
$134.40 |
$9.14M |
- |
| 2025-06-17 |
Tuckson Reed Vaughn |
Director |
限制性股票授予 (RSU) |
10,450 |
$2.32 |
$24.24K |
10,450 |
| 2025-06-17 |
Svoronos Dawn |
Director |
限制性股票授予 (RSU) |
10,450 |
$2.32 |
$24.24K |
10,450 |
| 2025-06-17 |
Nicholson, C. David |
Director |
限制性股票授予 (RSU) |
10,450 |
$2.32 |
$24.24K |
10,450 |
| 2025-06-17 |
Soparkar Peter |
Chief Operating Officer |
股份退回 |
40,000 |
$68.80 |
$2.75M |
- |
| 2025-06-17 |
Lupher, Jr. Mark L. |
Director |
限制性股票授予 (RSU) |
10,450 |
$2.32 |
$24.24K |
10,450 |
| 2025-06-17 |
Ozden Rabia Gurses |
Chief Medical Officer |
股份退回 |
8,000 |
$13.50 |
$108K |
- |
| 2025-06-17 |
Seyedkazemi Setareh |
Chief Development Officer |
股份退回 |
8,500 |
$12.90 |
$109.65K |
- |
| 2025-06-17 |
Hong Soo |
Director |
限制性股票授予 (RSU) |
10,450 |
$2.32 |
$24.24K |
10,450 |
| 2025-06-17 |
Kiss Szilard |
Director |
限制性股票授予 (RSU) |
10,450 |
$2.32 |
$24.24K |
10,450 |
| 2025-06-10 |
Seyedkazemi Setareh |
Chief Development Officer |
股份退回 |
40,000 |
$19.90 |
$796K |
- |
| 2025-05-15 |
Fischer Laurent |
CEO, President and Director |
知情卖出 |
9,126 |
$2.00 |
$18.25K |
87,488 |
| 2025-05-15 |
Soparkar Peter |
Chief Operating Officer |
知情卖出 |
2,960 |
$2.00 |
$5.92K |
39,154 |
| 2025-05-15 |
Seyedkazemi Setareh |
Chief Development Officer |
知情卖出 |
924 |
$2.00 |
$1.85K |
13,768 |
| 2025-04-23 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
50,000 |
$2.98 |
$148.95K |
191,800 |
| 2025-04-22 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
300,000 |
$3.00 |
$900K |
3,057,526 |
| 2025-04-02 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
15,209 |
$4.04 |
$61.41K |
2,757,526 |
| 2025-03-31 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
19,566 |
$4.38 |
$85.67K |
2,742,317 |
| 2025-03-27 |
Leonard Braden Michael |
10 Percent Owner |
知情卖出 |
16,593 |
$5.19 |
$86.09K |
141,800 |
| 2025-03-27 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
16,593 |
$5.19 |
$86.09K |
141,800 |
| 2025-03-26 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
20,407 |
$5.04 |
$102.84K |
125,207 |
| 2025-03-20 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
30,600 |
$5.61 |
$171.77K |
2,722,761 |
| 2025-03-19 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
25,000 |
$4.94 |
$123.39K |
2,692,161 |
| 2025-03-18 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
18,000 |
$4.60 |
$82.8K |
2,622,820 |
| 2025-02-28 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
85,068 |
$4.60 |
$391.02K |
2,604,820 |
| 2025-02-27 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
86,802 |
$4.46 |
$387.09K |
2,519,752 |
| 2025-02-26 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
164,886 |
$4.01 |
$660.98K |
2,432,950 |
| 2025-02-25 |
Rubinstein Linda M |
Chief Financial Officer |
限制性股票授予 (RSU) |
8,125 |
- |
- |
19,325 |
| 2025-02-25 |
Fischer Laurent |
CEO, President and Director |
限制性股票授予 (RSU) |
25,000 |
- |
- |
96,614 |
| 2025-02-25 |
Soparkar Peter |
Chief Operating Officer |
限制性股票授予 (RSU) |
13,125 |
- |
- |
42,114 |
| 2025-02-25 |
Ozden Rabia Gurses |
Chief Medical Officer |
限制性股票授予 (RSU) |
8,125 |
- |
- |
8,125 |
| 2025-02-25 |
Seyedkazemi Setareh |
Chief Development Officer |
限制性股票授予 (RSU) |
8,125 |
- |
- |
14,692 |
| 2024-08-02 |
Rubinstein Linda M |
Chief Financial Officer |
限制性股票授予 (RSU) |
62,083 |
$7.15 |
$443.89K |
62,083 |
| 2024-08-02 |
Fischer Laurent |
CEO, President and Director |
限制性股票授予 (RSU) |
200,000 |
$7.15 |
$1.43M |
200,000 |
| 2024-08-02 |
Soparkar Peter |
Chief Operating Officer |
限制性股票授予 (RSU) |
64,394 |
$7.15 |
$460.42K |
64,394 |
| 2024-08-02 |
Ozden Rabia Gurses |
Chief Medical Officer |
限制性股票授予 (RSU) |
44,010 |
$7.15 |
$314.67K |
44,010 |
| 2024-08-02 |
Seyedkazemi Setareh |
Chief Development Officer |
限制性股票授予 (RSU) |
43,458 |
$7.15 |
$310.72K |
43,458 |
| 2024-07-30 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
85,800 |
$7.15 |
$613.47K |
2,268,064 |
| 2024-07-18 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
80,718 |
$9.11 |
$735.74K |
2,182,264 |
| 2024-07-17 |
Leonard Braden Michael |
10 Percent Owner |
处置 |
- |
- |
- |
104,800 |
| 2024-07-17 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
135,546 |
$7.75 |
$1.05M |
2,101,546 |
| 2024-06-17 |
Whitcup Scott M |
Director |
限制性股票授予 (RSU) |
10,520 |
$7.32 |
$77.01K |
10,520 |
| 2024-06-17 |
Machado Patrick |
Director |
限制性股票授予 (RSU) |
3,300 |
$7.32 |
$24.16K |
3,300 |
| 2024-06-17 |
Scopa James Paul |
Director |
限制性股票授予 (RSU) |
10,520 |
$7.32 |
$77.01K |
10,520 |
| 2024-06-17 |
Tuckson Reed Vaughn |
Director |
限制性股票授予 (RSU) |
10,520 |
$7.32 |
$77.01K |
10,520 |
| 2024-06-17 |
Svoronos Dawn |
Director |
限制性股票授予 (RSU) |
10,520 |
$7.32 |
$77.01K |
10,520 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
